Amgen Inc.
AMGNNASDAQGSTrackedESG Rated: 2/2 ProvidersMarket Data VerifiedHealth CareBiotechnologyMSCI: AASustainalytics: 22.0 · Medium
- Coverage
- Rated universe Carries an MSCI or Sustainalytics observation.
- ESG profile reviewed
- Last editorial update to this profile.
- Quote
- Last verified closeObservation time is shown beside the price.
- Methodology
- How we rateProvider ratings are shown separately, never blended.
Market overview
Down−USD 1.39 (−0.30%) Day change
The market is closed. This is the last verified closing quote, not an intraday price.
- Open
- USD 467.53
- Previous close
- USD 467.06
- Day high
- USD 468.00
- Day low
- USD 462.22
- Volume
- 2,122,345
- Market cap
- USD 251,886,256,128
View Chart Data
| Date and time | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| USD 337.90 | USD 345.84 | USD 335.12 | USD 336.00 | 3,413,500 | |
| USD 321.82 | USD 323.00 | USD 313.18 | USD 313.85 | 2,924,900 | |
| USD 328.77 | USD 329.19 | USD 325.01 | USD 327.64 | 1,539,700 | |
| USD 328.70 | USD 333.03 | USD 326.90 | USD 330.41 | 4,033,700 | |
| USD 341.24 | USD 349.50 | USD 338.59 | USD 338.59 | 4,040,000 | |
| USD 377.91 | USD 379.93 | USD 374.13 | USD 375.50 | 2,427,000 | |
| USD 364.20 | USD 369.76 | USD 361.71 | USD 369.53 | 2,443,000 | |
| USD 351.80 | USD 353.42 | USD 348.61 | USD 349.77 | 2,368,700 | |
| USD 345.61 | USD 351.33 | USD 342.35 | USD 349.81 | 2,666,400 | |
| USD 345.52 | USD 350.69 | USD 345.50 | USD 348.62 | 2,033,400 | |
| USD 329.48 | USD 332.33 | USD 328.00 | USD 331.70 | 2,443,200 | |
| USD 340.26 | USD 343.80 | USD 338.40 | USD 339.30 | 1,566,200 | |
| USD 348.24 | USD 349.64 | USD 342.62 | USD 344.57 | 3,388,200 | |
| USD 350.06 | USD 359.10 | USD 350.06 | USD 352.82 | 2,340,900 | |
| USD 363.04 | USD 363.29 | USD 355.73 | USD 360.45 | 2,064,700 | |
| USD 383.25 | USD 398.00 | USD 382.21 | USD 393.10 | 3,413,000 | |
| USD 413.31 | USD 418.19 | USD 409.00 | USD 416.18 | 2,065,500 | |
| USD 433.08 | USD 442.13 | USD 431.01 | USD 436.99 | 1,761,500 | |
| USD 381.94 | USD 384.61 | USD 376.76 | USD 381.50 | 2,714,400 | |
| USD 411.52 | USD 419.02 | USD 410.96 | USD 418.13 | 2,917,900 | |
| USD 420.34 | USD 420.35 | USD 411.04 | USD 412.84 | 2,319,600 | |
| USD 441.03 | USD 454.66 | USD 439.57 | USD 451.83 | 2,910,500 | |
| USD 479.61 | USD 482.48 | USD 464.13 | USD 478.48 | 4,618,500 | |
| USD 471.86 | USD 474.00 | USD 466.92 | USD 467.06 | 2,827,600 |
Company Profile & Business Model Overview
Sustainability Strengths & Catalysts (Pros)
- Has a strong product pipeline with potential blockbuster drugs in development
- Is a leader in the biotechnology space and has a large market share
- Has a good ESG rating
Material Risks & Governance Concerns (Cons)
- Its recent performance has been lacklustre
- Faces stiff competition from other companies in the space
Related ESG Peer Equities
Companies in Health Care evaluated across carbon intensity, social metrics, and board governance.
ESG & Sustainability Rating Breakdown
MSCI and Sustainalytics ratings shown side by side, never blended into a single score.
Third-party ratings
MSCI ESG industry rating benchmark.
Medium
Data integrity and methodology
MSCI and Sustainalytics ratings are shown separately with their own observation dates; they are not blended into one score, and providers can disagree. Market quotes are delayed or last-close values, and every snapshot states its source and observation time. Read the full rating methodology.
Financial & Valuation Fundamentals
Valuation metrics for this profile. Market cap is taken from the delayed market quote above.
Related ESG Financial Tools & Modeling
ESG Investment Growth Calculator
Project compound future portfolio values versus traditional index benchmarks.
Launch Tool →
Portfolio Carbon Footprint Calculator
Translate your investment capital into financed greenhouse gas emissions.
Launch Tool →
Green Mortgage Calculator
Calculate interest rate discounts on energy-efficient certified homes.
Launch Tool →
Featured Sustainable Investment Research & Guides
Top 12 Impact Investing Apps & Platforms (Reviewed)
Comprehensive review of the best ESG micro-investing and direct indexing apps.
Biblically Responsible Investing (BRI): Top Stocks & Funds
Faith-based screening criteria, ESG alignment, and values-based portfolio strategies.
Top Desalination & Clean Water Infrastructure Stocks
Invest in global clean water purification, reverse osmosis, and municipal utilities.
Best Certified B-Corp Banks & Sustainable Banking
How to align your everyday cash reserves with social and climate impact standards.
Frequently Asked Questions
Direct answers on sustainability scores, risk methodologies, and peer rankings.
What is Amgen Inc. (AMGN)'s ESG rating and sustainability score?
Amgen Inc. (AMGN) currently holds an MSCI ESG rating of AA and a Sustainalytics ESG Risk Score of 22.0 (Medium risk). Ratings evaluate environmental emissions, labor standards, board independence, and regulatory compliance.
Is Amgen Inc. considered an ESG leader or laggard in Health Care?
Amgen Inc. is classified as an ESG Leader by MSCI with a AA rating, ranking in the top tier of companies in Health Care for sustainability governance and decarbonization practices.
What are the main ESG risks and controversies for Amgen Inc.?
Key material risks for Amgen Inc. include: Its recent performance has been lacklustre; Faces stiff competition from other companies in the space. Investors should evaluate whether corporate mitigation plans adequately address these vulnerabilities.
How does The Impact Investor evaluate ESG stock profiles?
The Impact Investor presents third-party ratings from MSCI and Sustainalytics alongside delayed market data and financial fundamentals. We do not blend ratings into proprietary black-box scores, and ratings are never modified by advertising or affiliate relationships.